LONDON - Another UK antibody company was swept up, as Novartis AG sealed a recommended all-cash offer worth £305.1 million (US$569 million) for NeuTec Pharma plc, paying more than twice the Manchester-based company's market capitalization. (BioWorld Today) Read More
